Skip to main content
. 2019 Feb 27;30(4):e60. doi: 10.3802/jgo.2019.30.e60

Table 1. Characteristics associated with patients with BRCA negative and VUS mutations.

Characteristics Negative VUS p-value
Age at testing, Median (Range) 46 (26–79) 46 (26–79)
VUS type - 99
Unknown - 79 (80)
Favor polymorphism - 18 (18)
Suspect deleterious - 2 (2)
Race 0.000
Non-caucasian 15 (15) 45 (46)
Caucasian 74 (75) 44 (44)
Not reported 10 (10) 10 (10)
Ethnicity 0.000
Ashkenazi 43 (43) 75 (76)
Non-Ashkenazi 37 (37) 11 (11)
Not reported 19 (19) 13 (13)
Parity 0.101
0 40 (40) 29 (29)
≥1 59 (60) 70 (71)
Menopausal status 0.155
Premenopausal 68 (69) 54 (56)
Perimenopausal 4 (4) 10 (10)
Postmenopausal 25 (25) 32 (32)
Unknown 2 (2) 3 (3)
OCPs prior to RRBSO 0.054
Yes 56 (57) 39 (39)
No 20 (20) 28 (28)
Unknown 23 (23) 32 (32)
Personal history of breast cancer* 74 (75) 79 (80) 0.396
Personal history of gynecologic cancer* 1 (1) 3 (3) 0.621
Family history of breast cancer* 65 (66) 64 (68) 0.878
Family history of all gynecologic cancers* 20 (20) 18 (19) 0.312
Family history of ovarian cancer* 19 (19) 12 (12) 0.171
RRBSO 0.305
No 80 (81) 74 (76)
Yes 19 (19) 25 (25)

Values are presented as number (%).

Chi-square and Fisher's exact tests for small cells for categorical variables, and t-tests for continuous variables.

VUS, variants of unknown significance; OCP, oral contraceptive pills; RRBSO, risk-reducing bilateral salpingo-oophorectomy.

*Patients with unknown cancer history were excluded from this analysis.